Menu
Scroll to top
Topic: INQ
Winning the hearts, minds (and pockets) of doctors

Winning the hearts, minds (and pockets) of doctors

If Novo Nordisk is to fulfil the potential of its anti-obesity drug Saxenda, it needs more doctors to have a new understanding of how obesity really works. And to prescribe. Again and again.

Obesity, politics, money and a company called Novo Nordisk

Obesity, politics, money and a company called Novo Nordisk

Novo Nordisk wants to change the way Australians think about obesity. And if it is successful, it could make a killing.

A message from the editor of INQ

A message from the editor of INQ

This week Crikey announced its new 'inquiry journalism' unit INQ. We’re looking to do things differently.

Warning: Crikey is about to unleash a dozen nosy inquiry journalists into the world

Warning: Crikey is about to unleash a dozen nosy inquiry journalists into the world

INQ, a team of a dozen reporters and editors — and our biggest single investment in journalism — will launch in two weeks.